logo

Vertex Pharmaceuticals Inc. (VRTX)



Trade VRTX now with
  Date
  Headline
8/26/2021 7:05:58 AM Vertex Publishes Phase 3 Results For TRIKAFTA In Cystic Fibrosis In The New England Journal Of Medicine
8/4/2021 8:34:16 AM Vertex Appoints Stuart Arbuckle As COO
7/29/2021 4:16:51 PM Vertex Pharma Q2 EPS $0.26 Vs. $3.18 Year Ago
7/29/2021 4:14:14 PM Vertex Pharmaceuticals Inc. (VRTX) Has Raised Its 2021 Revenue Estimate To $7.2 - $7.4 Bln From $6.7 - $6.9 Bln
7/28/2021 8:05:17 AM Vertex To Initiate Phase 3 Development Program For Once-Daily Triple Combination Regimen In People With Cystic Fibrosis
6/28/2021 9:31:43 AM Vertex Announces National Reimbursement Deal In France For KAFTRIO And SYMKEVI For Eligible Cystic Fibrosis Patients
6/11/2021 3:11:59 AM Vertex, CRISPR Announce New Data On 22 Patients Treated With Investigational CRISPR/Cas9-based Gene-editing Therapy
4/29/2021 4:13:30 PM Vertex Pharma Q1 EPS $2.49 Vs. $2.29 Year Ago
4/22/2021 8:08:03 AM Vertex, Obsidian Therapeutics Collaborate To Discover Novel Therapies That Regulate Gene Editing